Showing results (1041-1050 of 1,286) with videos related to
Sort By:
Pageof 129
Journal of Cardiovascular Pharmacology and Therapeutics|January 27, 2009
Macrophage depletion in hypertensive rats accelerates development of cardiomyopathyHarmen R Zandbergen, Umesh C Sharma, Sudhir Gupta, et al.Journal of Cardiovascular Pharmacology and Therapeutics|September 3, 2009
Efficacy and safety of ezetimibe plus orlistat or rimonabant in statin-intolerant nondiabetic overweight/obese patients with dyslipidemiaMatilda Florentin, Michael S Kostapanos, Eleni S Nakou, et al.Journal of Cardiovascular Pharmacology and Therapeutics|July 21, 2009
Statins reduce appropriate cardioverter-defibrillator shocks and mortality in patients with heart failure and combined cardiac resynchronization and implantable cardioverter-defibrillator therapyHarit Desai, Wilbert S Aronow, Fausan S Tsai, et al.Journal of Cardiovascular Pharmacology and Therapeutics|April 3, 2009
Modest dietary reductions in blood cholesterol have important public health benefitsCharles H Hennekens, Wendy R Schneider, E Joan Barice, et al.Journal of Cardiovascular Pharmacology and Therapeutics|March 31, 2009
Ranolazine as an adjunct to cardioplegia: a potential new therapeutic applicationHyosook Hwang, Joseph M Arcidi, Sharon L Hale, et al.Journal of Cardiovascular Pharmacology and Therapeutics|July 17, 2009
Application of zinc-bis-(DL-hydrogensaspartate) does not reduce apoptotic cell death in myocardial infarction in the rat heartErnst R Schwarz, Tanja Tussing, Erik Skobel, et al.Journal of Cardiovascular Pharmacology and Therapeutics|July 14, 2009
Heart rate variability increases with reductions in cigarette smoke exposure after 3 daysSagar Munjal, Tamara Koval, Raheema Muhammad, et al.Journal of Cardiovascular Pharmacology and Therapeutics|December 31, 2005
Bivalirudin vs heparin in percutaneous coronary intervention: a pooled analysisRamin Ebrahimi, A Michael Lincoff, John A Bittl, et al.Journal of Cardiovascular Pharmacology and Therapeutics|December 31, 2005
Intramyocardial injection of allogenic bone marrow-derived mesenchymal stem cells without immunosuppression preserves cardiac function in a porcine model of myocardial infarctionRaj R Makkar, Matthew J Price, Michael Lill, et al.Journal of Cardiovascular Pharmacology and Therapeutics|December 31, 2005
Heparin therapy leads to platelet activation and prolongation of PFA-100 closure timeMarlene S Williams, Ladina S Ng'allaPageof 129